**Core Concept**
Diethylstilbestrol (DES) is a synthetic estrogen that was prescribed to pregnant women between 1940 and 1971 to prevent miscarriages and other pregnancy complications. However, it was later found to have teratogenic effects on the developing fetus, particularly in the female reproductive system. Exposure to DES in-utero has been linked to various reproductive tract abnormalities and increased risk of certain cancers.

**Why the Correct Answer is Right**
The patient's history of in-utero DES exposure increases her risk of developing clear cell adenocarcinoma of the vagina and cervix. This is because DES stimulates the growth of the vaginal and cervical epithelium, leading to abnormal cell proliferation and an increased risk of malignant transformation. The clear cell type of adenocarcinoma is particularly associated with DES exposure, as it is a rare and aggressive form of cancer that is distinct from the more common squamous cell carcinoma.

**Why Each Wrong Option is Incorrect**
**Option A:** Adenomyosis is a condition characterized by the growth of endometrial tissue into the myometrium, which is not directly related to DES exposure.

**Option C:** Lichen sclerosus is a chronic skin condition that affects the genital and anal areas, but it is not associated with DES exposure.

**Option D:** Squamous cell carcinoma is a type of cancer that is more common in the cervix and vagina than clear cell adenocarcinoma, but it is not specifically linked to DES exposure.

**Clinical Pearl / High-Yield Fact**
It is essential to take a thorough medical and family history, including any exposure to DES, in patients presenting with vaginal or cervical cancer, as this information can inform treatment decisions and improve outcomes.

**✓ Correct Answer: B. Clear cell adenocarcinoma**